ストックスクリーナーアプリを入手
24.70
1.93%
-0.485
アフターアワーズ：
24.70
-0.0022
-0.01%
前日終値:
$25.19
開ける：
$24.9
24時間の取引高:
5,499
Relative Volume:
1.82
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.99%
1か月 パフォーマンス:
-6.27%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$24.69
$24.90
1週間の範囲:
$24.69
$25.33
52週間の値動き範囲:
$24.69
$28.19
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Company Profile
Amplify Weight Loss Drug Treatment Etf (THNR) 最新ニュース
Amplify ETFs Hits $10 Billion in Assets Amid New ETF LaunchesVettaFiCommentaries - Advisor Perspectives
(THNR) Investment Analysis and Advice - Stock Traders Daily
JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail
When the Price of (THNR) Talks, People Listen - Stock Traders Daily
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR - Yahoo Finance
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Yahoo Finance
(THNR) Trading Signals - Stock Traders Daily
7 Best Marijuana ETFs to Consider in 2024 - The Motley Fool
(THNR) Technical Pivots with Risk Controls - Stock Traders Daily
Tap the Weight-Loss Drug Market With These ETFs - Yahoo Finance
Long Term Trading Analysis for (THNR) - Stock Traders Daily
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst - MSN
Nervous about Nvidia? Here are some other stocks to consider - Yahoo Finance UK
3 ETFs to stabilize a portfolio amid volatility: Amplify CEO - Yahoo Finance
Harbour Investments Inc. Sells 275 Shares of First Trust Nasdaq Artificial Intelligence and Robotics ETF (NASDAQ:ROBT) - Defense World
Humana Inc. (NYSE:HUM) Shares Acquired by Harbour Investments Inc. - Defense World
Harbour Investments Inc. Has $166,000 Holdings in Innovator U.S. Equity Buffer ETF – June (BATS:BJUN) - Defense World
Harbour Investments Inc. Acquires New Position in Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) - Defense World
F M Investments LLC Invests $1.57 Million in General Motors (NYSE:GM) - Defense World
(THNR) Investment Report - Stock Traders Daily
8 weight-loss stocks for a fatter wallet as drugs like Ozempic supercharge the healthcare industry - Business Insider
Disruptive Theme of the Week: Playing Defense - ETFdb.com
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - MSN
'Ozempic breasts' to 'Ozempic face': What you need to know about weight loss drug side effects - Yahoo News Canada
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss - Yahoo News UK
Dr. Sanjay Gupta On Call: What are your questions about weight loss drugs? - Yahoo Lifestyle UK
This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Finds - Yahoo News Canada
Weight loss drug Zepbound outperforms Ozempic in new published study - Yahoo News Canada
Weight loss drug may cut heart failure risk, company says - Yahoo News Australia
Novo Nordisk's Wegovy gets UK approval for use to lower heart risks - Yahoo News UK
Oats could mimic effects of weight loss drugs, new study finds - Yahoo Lifestyle UK
Stephen Fry 'threw up five times a day' while using Ozempic - Yahoo News UK
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesity - Yahoo News Canada
NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers - Yahoo News Canada
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
Oprah Sets ABC Special on Ozempic and More Weight Loss Drugs After Exiting WeightWatchers Board - Yahoo News Canada
Returns Spiking for This Rate-Sensitive ETFVettaFiCommentaries - Advisor Perspectives
Would you consider taking weight loss drugs like Ozempic? Poll of the week - Yahoo Lifestyle UK
Hunter McGrady says she was 'utterly miserable' as a 'size 2/4': 'Weight loss doesn't always equate to confidence' - Yahoo Canada Shine On
HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside - Seeking Alpha
Make Money and Live Better With These Health Investing Tips - Bloomberg
Where to Invest in Health Trends - Bloomberg
Ozempic may reduce dementia: Research - Yahoo New Zealand News
THNR News Today | Why did Amplify Weight Loss Drug & Treatment ETF go up today? - MarketBeat
ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials - Yahoo Singapore News
Amplify Weight Loss Drug Treatment Etf (THNR) 財務データ
Amplify Weight Loss Drug Treatment Etf (THNR) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.69%
1.45%
大文字化:
|
ボリューム (24 時間):